Cargando…

Editorial: Cell Death and Targeted Cancer Therapies

Detalles Bibliográficos
Autores principales:	Bagci-Onder, Tugba, Kutuk, Ozgur, Chonghaile, Triona Ni, Knippschild, Uwe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296767/ https://www.ncbi.nlm.nih.gov/pubmed/35874828 http://dx.doi.org/10.3389/fcell.2022.967720

Ejemplares similares

Editorial: Targeted therapies for aggressive cancers
por: Lee, Sean B., et al.
Publicado: (2023)

Editorial: PROTACs: Targeted therapies for cancer treatment
por: Tabassum, Sobia
Publicado: (2023)

Editorial: PROTACs: Targeted therapies for cancer treatment
por: Tabassum, Sobia
Publicado: (2023)

Editorial: Ion and Water Transport in Cell Death
por: Ritter, Markus, et al.
Publicado: (2021)

Editorial: Epigenetic therapy against cancer: toward new molecular targets and technologies
por: Sousa, Ângela, et al.
Publicado: (2023)

Editorial: Dynamical Networks of Life/Death Decisions in a Cell: From DNA Repair to Cell Death
por: Lavrik, Inna N.
Publicado: (2021)

Editorial: Editor’s Pick 2021: Highlights in Cell Death and Survival
por: He, You-Wen, et al.
Publicado: (2022)

Editorial: Non-apoptotic cell death mechanisms and their therapeutic significance
por: Lopus, Manu, et al.
Publicado: (2022)

Editorial: Cell death: from its induction to the removal of dying cells!
por: Tanzer, Maria C., et al.
Publicado: (2023)

Critical View of Novel Treatment Strategies for Glioblastoma: Failure and Success of Resistance Mechanisms by Glioblastoma Cells
por: Burster, Timo, et al.
Publicado: (2021)

Editorial: Autophagy-Mediated Cell Survival and Death in Disease Progression and Treatment
por: Chen, Yongqiang, et al.
Publicado: (2022)

Editorial: Pannexin and connexin signaling in cell death and tissue health and disease
por: Mesnil, Marc, et al.
Publicado: (2023)

Editorial: Kinase inhibitors in cancer therapy
por: Yadav, Dharmendra Kumar
Publicado: (2022)

Editorial: Tumor microenvironment and cancer therapy
por: Xie, Yi, et al.
Publicado: (2023)

Editorial: Yeast Differentiation: From Cell-to-Cell Heterogeneity to Replicative Aging and Regulated Cell Death
por: Hardwick, J. Marie, et al.
Publicado: (2022)

Editorial: New insights into molecular mechanisms and targeted therapy for gastrointestinal tumors
por: Feng, Haoran, et al.
Publicado: (2023)

Editorial: Targeting Heterogeneity of Mesenchymal Stem Cells
por: Zhang, Qi, et al.
Publicado: (2022)

Editorial: Cell therapy, liver diseases, and regeneration
por: Zhang, Wencheng, et al.
Publicado: (2022)

Targeting Programmed Cell Death to Improve Stem Cell Therapy: Implications for Treating Diabetes and Diabetes-Related Diseases
por: Zhang, Qi, et al.
Publicado: (2021)

Editorial: Tumor Microenvironment and Cancer Cell Interactions in Solid Tumor Growth and Therapy Resistance
por: Ruocco, Maria Rosaria, et al.
Publicado: (2022)

Editorial: Tissue Engineering and Cell Therapy for Cartilage Restoration
por: Fernandes, Tiago Lazzaretti, et al.
Publicado: (2022)

Editorial: Molecular drivers of prostate cancer pathogenesis and therapy resistance
por: Patel, Girijesh Kumar, et al.
Publicado: (2023)

CK1δ in lymphoma: gene expression and mutation analyses and validation of CK1δ kinase activity for therapeutic application
por: Winkler, B. Sophia, et al.
Publicado: (2015)

Identification of the Host Substratome of Leishmania-Secreted Casein Kinase 1 Using a SILAC-Based Quantitative Mass Spectrometry Assay
por: Smirlis, Despina, et al.
Publicado: (2022)

Editorial: Lipids and Membrane Contacts in Yeast—Structure, Functional Aspects and Implications on Ageing, Cell Death and Autophagy
por: Rockenfeller, Patrick, et al.
Publicado: (2022)

Editorial: Targeting Lipid Rafts as a Strategy Against Infection and Cancer
por: Garofalo, Tina, et al.
Publicado: (2021)

Editorial: The adipose tissue microenvironment in cancer: Molecular mechanisms and targets for treatment
por: Yang, Yunlong
Publicado: (2022)

Editorial: Metabolism and Cell Adhesion in Cancer
por: Hartmann, Tanja Nicole
Publicado: (2022)

Editorial: Targeting Bruton Tyrosine Kinase
por: Brunner, Cornelia, et al.
Publicado: (2022)

Editorial: Epigenetic Therapy With Histone Deacetylase Inhibitors: Implications for Cancer Treatment
por: Sousa, Angela, et al.
Publicado: (2021)

Targeting Cell Death: Pyroptosis, Ferroptosis, Apoptosis and Necroptosis in Osteoarthritis
por: Yang, Jian, et al.
Publicado: (2022)

Editorial: Advancing gene and cell therapy using human mesenchymal stem cells
por: Liu, Tong Ming, et al.
Publicado: (2023)

Editorial: Cellular reprogramming in development, disease, and design of cell-replacement therapies
por: Burke, Zoë D., et al.
Publicado: (2023)

Editorial: Targeting Developmental Pathways in Inflammation and Disease
por: Anastasiadou, Eleni, et al.
Publicado: (2021)

A bibliometric analysis of PIN1 and cell death
por: Zhang, Jia-Heng, et al.
Publicado: (2022)

Editorial: Reprogramming Stromal Cells in Chronic Inflammation and Cancer
por: Igea, Ana, et al.
Publicado: (2021)

Editorial: Inflammation and Myeloid Cells in Cancer Progression and Metastasis
por: Mishra, Sanjay, et al.
Publicado: (2022)

Editorial: Cell signaling in cancer metastasis and lineage plasticity
por: Yang, Wei, et al.
Publicado: (2023)

Editorial: Targeting Dysregulated Inflammation to Treat Cardiovascular Diseases
por: Buelna-Chontal, Mabel, et al.
Publicado: (2022)

Editorial: Nanomaterials for targeted delivery of therapeutic and imaging agents
por: Chockalingam, S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6gqippqdu12a6tagqajdps1ljf